Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Pyxis Oncology Inc.

    NASDAQ: PYXS · Real-Time Price · USD
    1.34
    0.10 (8.06%)
    At close: Jun 06, 2025, 1:28 PM

    Pyxis Oncology Statistics

    Share Statistics

    Pyxis Oncology has 61.95M shares outstanding. The number of shares has increased by 4.59% in one year.

    Shares Outstanding

    n/a
    		 61.95M

    Shares Change (YoY)

    n/a
    		 4.59%

    Shares Change (QoQ)

    n/a
    		 3.57%

    Owned by Institutions (%)

    n/a
    		 51.94%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 5,281

    FTD / Avg. Volume

    n/a
    		 1.09%

    Short Selling Information

    The latest short interest is 7.05M, so 11.38% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 7.05M

    Short % of Shares Out

    n/a
    		 11.38%

    Short % of Float

    n/a
    		 13.77%

    Short Ratio (days to cover)

    n/a
    		 13.52

    Valuation Ratios

    The PE ratio is -1.18 and the forward PE ratio is -1.06. Pyxis Oncology's PEG ratio is 0.04.

    PE Ratio

    n/a
    		 -1.18

    Forward PE

    n/a
    		 -1.06

    PS Ratio

    n/a
    		 5.65

    Forward PS

    n/a
    		 1.1

    PB Ratio

    n/a
    		 0.76

    P/FCF Ratio

    n/a
    		 -1.57

    PEG Ratio

    n/a
    		 0.04
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Pyxis Oncology.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 7.49, with a Debt / Equity ratio of 0.17.

    Current Ratio

    n/a
    		 7.49

    Quick Ratio

    n/a
    		 7.49

    Debt / Equity

    n/a
    		 0.17

    Debt / EBITDA

    n/a
    		 -0.31

    Debt / FCF

    n/a
    		 -0.35

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $366,954.55

    Profits Per Employee

    n/a
    		 $-1,757,522.73

    Employee Count

    n/a
    		 44

    Asset Turnover

    n/a
    		 0.1

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -2.16M

    Effective Tax Rate

    n/a
    		 2.72%

    Stock Price Statistics

    The stock price has increased by -64.97% in the last 52 weeks. The beta is 1.18, so Pyxis Oncology's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.18

    52-Week Price Change

    n/a
    		 -64.97%

    50-Day Moving Average

    n/a
    		 1.09

    200-Day Moving Average

    n/a
    		 2.12

    Relative Strength Index (RSI)

    n/a
    		 54.77

    Average Volume (20 Days)

    n/a
    		 486,319

    Income Statement

    In the last 12 months, Pyxis Oncology had revenue of 16.15M and earned -77.33M in profits. Earnings per share was -1.32.

    Revenue

    n/a
    		 16.15M

    Gross Profit

    n/a
    		 15.67M

    Operating Income

    n/a
    		 -89.46M

    Net Income

    n/a
    		 -77.33M

    EBITDA

    n/a
    		 -65.51M

    EBIT

    n/a
    		 -68.5M

    Earnings Per Share (EPS)

    n/a
    		 -1.32
    Full Income Statement

    Balance Sheet

    The company has 19.47M in cash and 20.2M in debt, giving a net cash position of -727K.

    Cash & Cash Equivalents

    n/a
    		 19.47M

    Total Debt

    n/a
    		 20.2M

    Net Cash

    n/a
    		 -727K

    Retained Earnings

    n/a
    		 -363.56M

    Total Assets

    n/a
    		 135.87M

    Working Capital

    n/a
    		 97.44M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -57.67M and capital expenditures -237K, giving a free cash flow of -57.91M.

    Operating Cash Flow

    n/a
    		 -57.67M

    Capital Expenditures

    n/a
    		 -237K

    Free Cash Flow

    n/a
    		 -57.91M

    FCF Per Share

    n/a
    		 -0.99
    Full Cash Flow Statement

    Margins

    Gross margin is 97.06%, with operating and profit margins of -554.07% and -478.95%.

    Gross Margin

    n/a
    		 97.06%

    Operating Margin

    n/a
    		 -554.07%

    Pretax Margin

    n/a
    		 -492.35%

    Profit Margin

    n/a
    		 -478.95%

    EBITDA Margin

    n/a
    		 -405.76%

    EBIT Margin

    n/a
    		 -554.07%

    FCF Margin

    n/a
    		 -358.66%

    Dividends & Yields

    PYXS does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for PYXS is $9, which is 625.8% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $9

    Price Target Difference

    n/a
    		 625.8%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 5
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -3.76

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist